Posts Tagged: Gilead Sciences


CIRM success story dies quiet death

Cancer cells. Cancer outbreak and treatment for malignant cancer. Image by Mohammed Haneefa Nizamudeencells in a human body. 3d illustration

A once-heralded research venture by the state of California that targeted “don’t eat me” signals that protect cancer cells has now ended. The potential treatment’s obituary boiled down to one phrase repeated six times and buried deep in a corporate document.


State stem cell agency’s first royalties: $15 million from Stanford

Stanford University, where major stem cell research is being conducted.(Photo: yhelfman, via Shutterstock)

The California stem cell agency says it has received $15.6 million in royalties from Stanford University, the largest such payment by far in the 17-year history of the state research agency. Until the announcement, the agency, officially known as the California Institute for Regenerative Medicine (CIRM), had received only $557,292 in royalties.

Support for Capitol Weekly is Provided by: